QMDx.jpg
QuantuMDx confirm its diagnostic tests remain able to detect all known variants of COVID-19 including the new variant from South Africa, B.1.1.529
November 26, 2021 07:37 ET | QuantuMDx Group Ltd
NEWCASTLE UPON TYNE, UK, 26 NOVEMBER 2021. QuantuMDx Group Limited (“QuantuMDx”), today confirms that both its SARS-CoV-2 assays for open PCR platforms and its rapid PCR device, Q-POC™, as well as its...
QMDx.jpg
QuantuMDx secures £15 million equity investment from Vita Spring and enters into Cooperation Agreement discussions with Sansure Biotech
November 08, 2021 07:00 ET | QuantuMDx Group Ltd
QuantuMDx secures £15 million equity investment from Vita Spring and enters into Cooperation Agreement discussions with Sansure Biotech Funds will be used to develop further multiplexing capabilities...
QMDx.jpg
QuantuMDx secures £15 million equity investment from Vita Spring and enters into Cooperation Agreement discussions with Sansure Biotech
November 08, 2021 02:00 ET | QuantuMDx Group Ltd
QuantuMDx secures £15 million equity investment from Vita Spring and enters into Cooperation Agreement discussions with Sansure Biotech Funds will be used to develop further multiplexing capabilities...
QMDx.jpg
QuantuMDx partners with Cignpost Diagnostics
August 16, 2021 02:00 ET | QuantuMDx Group Ltd
QuantuMDx partners with Cignpost Diagnostics Providing a rapid, PCR COVID-19 testing solution to the UK film & TV industry NEWCASTLE UPON TYNE, UK, 16 August 2021. QuantuMDx Group Limited has...
QMDx.jpg
QuantuMDx launches Q-POC™ - rapid PCR point of care diagnostic system
July 09, 2021 02:00 ET | QuantuMDx Group Ltd
QuantuMDx launches Q-POC™ - rapid PCR point of care diagnostic system Roll out at ECCMID 2021 with Q-POC™ SARS-CoV-2 assay96.9% sensitivity, 98.3% specificitySample to result - approximately 30...
QMDx.jpg
Prime Minister, Boris Johnson visits Newcastle-based QuantuMDx
February 13, 2021 10:30 ET | QuantuMDx Group Ltd
Prime Minister, Boris Johnson visits Newcastle-based QuantuMDx                     -          QuantuMDx has developed Q-POC™ - a rapid, PCR diagnostic device for coronavirus testing at the point of...
QMDx.jpg
QuantuMDx diagnostic test for SARS-CoV-2 remains suitable for the detection of all discovered variants, including VUI-202012/01
December 22, 2020 07:00 ET | QuantuMDx Group Ltd
QuantuMDx diagnostic test for SARS-CoV-2 remains suitable for the detection of all discovered variants, including VUI-202012/01 NEWCASTLE UPON TYNE, UK, 22 December 2020. QuantuMDx Group Limited...
QMDx.jpg
QuantuMDx embarks on £11 million scale-up to mass manufacture its diagnostic Q-POCTM device and disposable test cassette
December 17, 2020 07:00 ET | QuantuMDx Group Ltd
QuantuMDx embarks on £11 million scale-up to mass manufacture its diagnostic Q-POCTM device and disposable test cassette       -          Q-POC™ is a point of care molecular diagnostic system which...
QMDx.jpg
QuantuMDx embarks on £11 million scale-up to mass manufacture its diagnostic Q-POCTM device and disposable test cassette
December 17, 2020 02:00 ET | QuantuMDx Group Ltd
QuantuMDx embarks on £11 million scale-up to mass manufacture its diagnostic Q-POCTM device and disposable test cassette       -          Q-POC™ is a point of care molecular diagnostic system which...
QMDx.jpg
QuantuMDx embarks on £11 million scale-up to mass manufacture its diagnostic Q-POCTM device and disposable test cassette
December 16, 2020 19:00 ET | QuantuMDx Group Ltd
QuantuMDx embarks on £11 million scale-up to mass manufacture its diagnostic Q-POCTM device and disposable test cassette Q-POC™ is a point of care molecular diagnostic system which delivers results...